We will introduce a compassionate use protocol for treating 50 patients with massive PE by percutaneous catheter thrombectomy at selected academic hospitals in Switzerland, Germany, and the United States, using the Aspirex PE catheter thrombectomy device. We plan to enroll a minimum of 10 but no more than 20 patients at the University Hospital of Zurich from October 2005 to September 2007.